OKYO Pharma's OK-101: A Revolutionary Treatment for Dry Eye Disease. Dry Eye Disease (DED) is a prevalent condition affecting millions globally, characterized by discomfort, visual disturbance, and potential damage to the ocular surface. Despite the availability of various treatments, many patients continue to seek more effective solutions. In a significant development, OKYO Pharma has announced that its drug, OK-101, has achie...
$オキョ・ファーマ(OKYO.US)$OKYO Pharma Says OK-101 Achieves Statistical Significance For Multiple Signs And Symptoms Of Dry Eye Disease Including Ocular Pain Relief In Its First-in-Human Phase 2 Trial Of OK-101
$オキョ・ファーマ(OKYO.US)$Only positive i see right now is its bounced off the 20 and has stayed above so far on 5M
1
2
報告
leew1966 :
trytosaveabit do you us bother techs and financiql?i am trying to learn FA and i am learning to read it but can't find a place to get an updated copy of balance sheet, you know any ty
Trytosaveabitスレ主leew1966:
So my friend! I really want to answer your question! But I’m not sure what you’re asking? Sorry but please try again. Because i really want to try and help! GL
オキョ・ファーマに関するコメント
Dry Eye Disease (DED) is a prevalent condition affecting millions globally, characterized by discomfort, visual disturbance, and potential damage to the ocular surface. Despite the availability of various treatments, many patients continue to seek more effective solutions. In a significant development, OKYO Pharma has announced that its drug, OK-101, has achie...
まだコメントはありません